Cargando…
Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathway
BACKGROUND: Tumor cells may aberrantly express metabolic enzymes to adapt to their environment for survival and growth. Targeting cancer‐specific metabolic enzymes is a potential therapeutic strategy. Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the conversion of oxaloacetate to phosphoenolpy...
Autores principales: | Hsu, Hui‐Ping, Chu, Pei‐Yi, Chang, Tsung‐Ming, Huang, Kuo‐Wei, Hung, Wen‐Chun, Jiang, Shih Sheng, Lin, Hui‐You, Tsai, Hui‐Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883444/ https://www.ncbi.nlm.nih.gov/pubmed/35757841 http://dx.doi.org/10.1002/cam4.4969 |
Ejemplares similares
-
Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors
por: Chu, Pei-Yi, et al.
Publicado: (2017) -
Kinetic and functional properties of human mitochondrial phosphoenolpyruvate carboxykinase
por: Escós, Miriam, et al.
Publicado: (2016) -
Phosphoenolpyruvate Cycling via Mitochondrial Phosphoenolpyruvate Carboxykinase Links Anaplerosis and Mitochondrial GTP with Insulin Secretion
por: Stark, Romana, et al.
Publicado: (2009) -
Phosphoenolpyruvate carboxykinases as emerging targets in cancer therapy
por: Yu, Yong, et al.
Publicado: (2023) -
The requirement of phosphoenolpyruvate carboxykinase 1 for angiogenesis in vitro and in vivo
por: Yao, Jin, et al.
Publicado: (2022)